NUVBNuvation Bio Inc.
$4.57+26% 1Y
$4.57
$3.4152 weeks$9.54
Is the price fair?
What NUVB's price assumes
Nuvation Bio Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 9.44× revenue.
9.44
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 6.32
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 7.02
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 6.32
- EV / EBIToperating margin −81%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 7.02
- Market capitalisation351.1 million shares, counted Aug 3, 2026
- $1.60B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks